Located in Gaithersburg, MD, OpGen is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. OpGen’s product portfolio includes UnyveroAcuitas AMR Gene Panel  and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction.


OpGen and its group companies are striving to innovate molecular microbiology.

Molecular-Microbiology-Innovation


Our combined portfolio has synergistic products and capabilities.

Portfolio with Synergistic Products and Capabilities

 

Corporate Presentation